D L Behrens

Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity

Charles F. Albright, Nilsa Graciani, Wei Han et al. · Molecular Cancer Therapeutics · 2005 · 103 citations

Immunology, Mmp-selective Metabolism, Pharmacotherapy +20

Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.

JL Gross, D L Behrens, Deborra Mullins et al. · PubMed · 1988 · 93 citations

Chemoprevention Strategy, Cellular Pharmacology, Urokinase-type Pa +18

Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium.

Shih-Fong Chen, Frank W. Perrella, D L Behrens et al. · PubMed · 1992 · 84 citations

Ubiquinone Q6, Medicinal Chemistry, Pharmaceutical Chemistry +15

Phospholipase C Inhibitors: A New Class of Agents

Frank W. Perrella, Shih-Fong Chen, D L Behrens et al. · Journal of Medicinal Chemistry · 1994 · 58 citations

High Throughput Quantitation of cAMP Production Mediated by Activation of Seven Transmembrane Domain Receptors

Ilona Kariv, Michelle E. Stevens, D L Behrens et al. · SLAS DISCOVERY · 1999 · 48 citations